Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations.
Saved in:
| Title: | Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations. |
|---|---|
| Authors: | Artin J; Rheumatology and Clinical Immunology Unit of Internal Medicine Department, Cairo University, Cairo, Egypt., Elsabagh YA; Rheumatology and Clinical Immunology Unit of Internal Medicine Department, Cairo University, Cairo, Egypt., Rashed L; Medical Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt., Hussein MA; Rheumatology and Clinical Immunology Unit of Internal Medicine Department, Cairo University, Cairo, Egypt. |
| Source: | Archives of rheumatology [Arch Rheumatol] 2022 Oct 21; Vol. 38 (2), pp. 249-256. Date of Electronic Publication: 2022 Oct 21 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Bayçınar Tıbbi Yayıncıhk ve Reklam Hiz, Tic. Ltd. Şti Country of Publication: Turkey NLM ID: 101639000 Publication Model: eCollection Cited Medium: Internet ISSN: 2618-6500 (Electronic) Linking ISSN: 21485046 NLM ISO Abbreviation: Arch Rheumatol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2618-6500 |
|---|---|
| DOI: | 10.46497/ArchRheumatol.2023.9638 |
